Can Trump take credit for North Carolina’s booming biopharma industry? Which drugs could get a shortcut to the market? And who wore a tuxedo to the STAT Summit?
We discuss all that and more in the latest episode of “The Readout LOUD.”
Elaine is out this week, so Adam and Allison dive into the latest news in the life science industry together, including the two companies pushing the Food and Drug Administration, the first recipients of the Commissioner’s National Priority Review voucher, and why Flagship Pioneering founder Nobuar Afeyan thinks that mRNA vaccines are the canary in the coal mine that is the drug industry. Adam also asks Allison about her trip to North Carolina to check out the local biomanufacturing boom.
To read Allison’s story on how North Carolina built a biomanufacturing boomtown, go here; for Afeyan’s warning to the drug industry, go here; for the latest on Moderna’s CMV vaccine trial, go here; for more on the priority drug review voucher recipients, go here; and to read about plans to expand on the innovation that saved Baby KJ, go here.
Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
